Aptevo Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$4.47

-0.08 (-1.76%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +532.0% upside

Low Target $22.50

Average Target $28.25

High Target $48.31

Current Price $4.47

Current
$4.47

Target
$28.25

$22.50 $28.25 avg $48.31

Scenario Analysis

Bear Case

$22.50

403.4%

Low target

Base Case

$28.25

+532.0%

Avg target

Bull Case

$48.31

+980.8%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$61.72

-92.8% from high

52-Week Low

$3.80

+17.6% from low

Target vs 52W High

$28.25

-54.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.2%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.6%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-40.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-48.0%